BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Rheenen PF, Aloi M, Assa A, Bronsky J, Escher JC, Fagerberg UL, Gasparetto M, Gerasimidis K, Griffiths A, Henderson P, Koletzko S, Kolho KL, Levine A, van Limbergen J, Martin de Carpi FJ, Navas-López VM, Oliva S, de Ridder L, Russell RK, Shouval D, Spinelli A, Turner D, Wilson D, Wine E, Ruemmele FM. The Medical Management of Paediatric Crohn's Disease: an ECCO-ESPGHAN Guideline Update. J Crohns Colitis 2020:jjaa161. [PMID: 33026087 DOI: 10.1093/ecco-jcc/jjaa161] [Cited by in Crossref: 33] [Cited by in F6Publishing: 25] [Article Influence: 16.5] [Reference Citation Analysis]
Number Citing Articles
1 Mitrev N, Huang H, Hannah B, Kariyawasam VC. Review of exclusive enteral therapy in adult Crohn's disease. BMJ Open Gastroenterol 2021;8:e000745. [PMID: 34580154 DOI: 10.1136/bmjgast-2021-000745] [Reference Citation Analysis]
2 Devarapalli UV, Sarma MS, Mathiyazhagan G. Gut and liver involvement in pediatric hematolymphoid malignancies. World J Gastrointest Oncol 2022; 14(3): 587-606 [DOI: 10.4251/wjgo.v14.i3.587] [Reference Citation Analysis]
3 van Rheenen PF. Managing abnormal liver tests in children with inflammatory bowel disease. Curr Opin Pediatr 2021;33:521-9. [PMID: 34261897 DOI: 10.1097/MOP.0000000000001045] [Reference Citation Analysis]
4 Torun A, Hupalowska A, Trzonkowski P, Kierkus J, Pyrzynska B. Intestinal Microbiota in Common Chronic Inflammatory Disorders Affecting Children. Front Immunol 2021;12:642166. [PMID: 34163468 DOI: 10.3389/fimmu.2021.642166] [Reference Citation Analysis]
5 Tegtmeyer D, Flemming G, Klemann C. Chronisch-entzündliche Darmerkrankung: Die Nadel im Heuhaufen: Wann steckt ein angeborener Immundefekt dahinter? Monatsschr Kinderheilkd. [DOI: 10.1007/s00112-022-01425-8] [Reference Citation Analysis]
6 Choi S, Choi BS, Choe BH, Kang B. Successful treatment with vedolizumab in an adolescent with Crohn disease who had developed active pulmonary tuberculosis while receiving infliximab. Yeungnam Univ J Med 2021;38:251-7. [PMID: 33601494 DOI: 10.12701/yujm.2020.00878] [Reference Citation Analysis]
7 Ashton JJ, Ennis S, Beattie RM. Infliximab at diagnosis: moving towards personalisation in paediatric inflammatory bowel disease. Gut 2021:gutjnl-2021-324214. [PMID: 33722861 DOI: 10.1136/gutjnl-2021-324214] [Reference Citation Analysis]
8 Kleinhenz J, Wagner E. Biologics in Pediatric Inflammatory Bowel Disease. Pediatr Ann 2022;51. [DOI: 10.3928/19382359-20220113-01] [Reference Citation Analysis]
9 Kuenzig ME, Bitton A, Carroll MW, Kaplan GG, Otley AR, Singh H, Nguyen GC, Griffiths AM, Stukel TA, Targownik LE, Jones JL, Murthy SK, McCurdy JD, Bernstein CN, Lix LM, Peña-Sánchez JN, Mack DR, Jacobson K, El-Matary W, Dummer TJB, Fung SG, Spruin S, Nugent Z, Tanyingoh D, Cui Y, Filliter C, Coward S, Siddiq S, Benchimol EI; Canadian Gastro-Intestinal Epidemiology Consortium. Inflammatory bowel disease increases the risk of venous thromboembolism in children: a population-based matched cohort study. J Crohns Colitis 2021:jjab113. [PMID: 34175936 DOI: 10.1093/ecco-jcc/jjab113] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
10 Matuszczyk M, Kierkus J. Nutritional Therapy in Pediatric Crohn's Disease-Are We Going to Change the Guidelines? J Clin Med 2021;10:3027. [PMID: 34300192 DOI: 10.3390/jcm10143027] [Reference Citation Analysis]
11 Van Limbergen JE, Koot BGP, de Winter JP. Fool me once… treatment exposure to achieve remission in pediatric IBD. Eur J Pediatr 2020;179:1921-4. [PMID: 33135091 DOI: 10.1007/s00431-020-03862-7] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lin XX, Qiu Y, Zhuang XJ, Liu F, Wu XM, Chen MH, Mao R. Intestinal stricture in Crohn's disease: A 2020 update. J Dig Dis 2021;22:390-8. [PMID: 34014617 DOI: 10.1111/1751-2980.13022] [Reference Citation Analysis]
13 Wong K, Isaac DM, Wine E. Growth Delay in Inflammatory Bowel Diseases: Significance, Causes, and Management. Dig Dis Sci 2021;66:954-64. [PMID: 33433805 DOI: 10.1007/s10620-020-06759-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
14 Shimizu H, Ebana R, Kudo T, Sato T, Hara T, Hosoi K, Usami M, Yoshida M, Takeuchi I, Nakase H, Iwama I, Arai K, Shimizu T. Both fecal calprotectin and fecal immunochemical tests are useful in children with inflammatory bowel disease. J Gastroenterol 2022. [PMID: 35165800 DOI: 10.1007/s00535-022-01856-w] [Reference Citation Analysis]
15 Hu W, Feng Y, Ye Z, Tang Z, Qian L, Wang Y, Huang Y. The Association Between Genetic Variants, Pharmacokinetics, and Infliximab Efficacy in Pediatric Patients With Crohn's Disease in China. Front Pediatr 2021;9:744599. [PMID: 34966700 DOI: 10.3389/fped.2021.744599] [Reference Citation Analysis]
16 Eindor-Abarbanel A, Healey GR, Jacobson K. Therapeutic Advances in Gut Microbiome Modulation in Patients with Inflammatory Bowel Disease from Pediatrics to Adulthood. Int J Mol Sci 2021;22:12506. [PMID: 34830388 DOI: 10.3390/ijms222212506] [Reference Citation Analysis]
17 Armstrong H, Mander I, Zhang Z, Armstrong D, Wine E. Not All Fibers Are Born Equal; Variable Response to Dietary Fiber Subtypes in IBD. Front Pediatr 2020;8:620189. [PMID: 33520902 DOI: 10.3389/fped.2020.620189] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 7.0] [Reference Citation Analysis]
18 Kim ES, Kim MJ. Upper gastrointestinal tract involvement of Crohn disease: clinical implications in children and adolescents. Clin Exp Pediatr 2022;65:21-8. [PMID: 34530520 DOI: 10.3345/cep.2021.00661] [Reference Citation Analysis]
19 de Sire R, Nardone OM, Testa A, Calabrese G, Caiazzo A, Castiglione F. Exclusive Enteral Nutrition in Adult Crohn's Disease: an Overview of Clinical Practice and Perceived Barriers. Clin Exp Gastroenterol 2021;14:493-501. [PMID: 35002274 DOI: 10.2147/CEG.S267172] [Reference Citation Analysis]
20 Scarallo L, Lionetti P. Dietary Management in Pediatric Patients with Crohn's Disease. Nutrients 2021;13:1611. [PMID: 34064976 DOI: 10.3390/nu13051611] [Reference Citation Analysis]
21 Colman RJ, Xiong Y, Mizuno T, Hyams JS, Noe JD, Boyle B, D'Haens GR, van Limbergen J, Chun K, Yang J, Rosen MJ, Denson LA, Vinks AA, Minar P. Antibodies-to-infliximab accelerate clearance while dose intensification reverses immunogenicity and recaptures clinical response in paediatric Crohn's disease. Aliment Pharmacol Ther 2021. [PMID: 34935161 DOI: 10.1111/apt.16733] [Reference Citation Analysis]
22 Tran LC, Bridoux-Henno L, Gastineau S, Dabadie A, Carré E, Hugot JP, Martinez-Vinson C, Mosca A, Coopman S, Lamireau T, Enaud R, Clouzeau H, Bertrand V, Pigneur B, Ruemmele F, Degas V, Breton A, Mas E, Lacotte É, Chaillou-Legault E, Caron N, Languepin J, Willot S, Bouazza A, Spyckerelle C, Dimitrov G, Thomassin N, Djeddi D, Vanrenterghem A, Grandjean C, Viala J, Dupont-Lucas C. Functional abdominal pain disorders and patient- and parent- reported outcomes in children with inflammatory bowel disease in remission. Dig Liver Dis 2021:S1590-8658(21)00308-X. [PMID: 34187767 DOI: 10.1016/j.dld.2021.05.034] [Reference Citation Analysis]
23 Aardoom MA, Klomberg RCW, Kemos P, Ruemmele FM, van Ommen H, de Ridder L, Croft NM. The incidence and characteristics of venous thromboembolisms in paediatric-onset inflammatory bowel disease; a prospective international cohort study based on the PIBD-SETQuality Safety Registry. J Crohns Colitis 2021:jjab171. [PMID: 34599822 DOI: 10.1093/ecco-jcc/jjab171] [Reference Citation Analysis]
24 Shentova-eneva R, Velikova T. Laboratory Assessment of Disease Activity in Pediatric Patients with Inflammatory Bowel Disease: What’s New? Gastroenterology Insights 2020;11:58-71. [DOI: 10.3390/gastroent11020009] [Reference Citation Analysis]
25 Gatti S, Gelzoni G, Catassi GN, Catassi C. The Clinical Spectrum of Inflammatory Bowel Disease Associated With Specific Genetic Syndromes: Two Novel Pediatric Cases and a Systematic Review. Front Pediatr 2021;9:742830. [PMID: 34765575 DOI: 10.3389/fped.2021.742830] [Reference Citation Analysis]
26 Giachero F, Jenke A, Zilbauer M. Improving prediction of disease outcome for inflammatory bowel disease: progress through systems medicine. Expert Rev Clin Immunol 2021;17:871-81. [PMID: 34142929 DOI: 10.1080/1744666X.2021.1945442] [Reference Citation Analysis]
27 Salvador-Martín S, Melgarejo-Ortuño A, López-Fernández LA. Biomarkers for Optimization and Personalization of Anti-TNFs in Pediatric Inflammatory Bowel Disease. Pharmaceutics 2021;13:1786. [PMID: 34834201 DOI: 10.3390/pharmaceutics13111786] [Reference Citation Analysis]
28 Day AS. Aspects of the Pathogenesis and Management of Inflammatory Bowel Diseases. GastrointestDisord 2021;3:96-9. [DOI: 10.3390/gidisord3030010] [Reference Citation Analysis]
29 Kolho KL. Therapeutic Drug Monitoring and Outcome of Infliximab Therapy in Pediatric Onset Inflammatory Bowel Disease. Front Pediatr 2020;8:623689. [PMID: 33520903 DOI: 10.3389/fped.2020.623689] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
30 de Laffolie J, Zimmer KP, Sohrabi K, Hauer AC. Running Behind "POPO"-Impact of Predictors of Poor Outcome for Treatment Stratification in Pediatric Crohn's Disease. Front Med (Lausanne) 2021;8:644003. [PMID: 34513855 DOI: 10.3389/fmed.2021.644003] [Reference Citation Analysis]
31 Wang X, Xiao Y, Xu X, Guo L, Yu Y, Li N, Xu C. Characteristics of Fecal Microbiota and Machine Learning Strategy for Fecal Invasive Biomarkers in Pediatric Inflammatory Bowel Disease. Front Cell Infect Microbiol 2021;11:711884. [PMID: 34950604 DOI: 10.3389/fcimb.2021.711884] [Reference Citation Analysis]
32 Di Chio T, Sokollik C, Peroni DG, Hart L, Simonetti G, Righini-Grunder F, Borrelli O. Nutritional Aspects of Pediatric Gastrointestinal Diseases. Nutrients 2021;13:2109. [PMID: 34205445 DOI: 10.3390/nu13062109] [Reference Citation Analysis]
33 Laffolie J, Zimmer KP, Sohrabi K, Hauera AC. Early Immunosuppression in Children and Adolescents With Crohn's Disease. Dtsch Arztebl Int 2021;118:421-2. [PMID: 34369371 DOI: 10.3238/arztebl.m2021.0214] [Reference Citation Analysis]
34 Fang S, Song Y, Zhang C, Wang L. Efficacy and safety of vedolizumab for pediatrics with inflammatory bowel disease: a systematic review. BMC Pediatr 2022;22:175. [PMID: 35379216 DOI: 10.1186/s12887-022-03229-x] [Reference Citation Analysis]
35 Kunovsky L, Dite P, Jabandziev P, Kala Z, Vaculova J, Andrasina T, Hrunka M, Bojkova M, Trna J. Autoimmune Diseases of Digestive Organs-A Multidisciplinary Challenge: A Focus on Hepatopancreatobiliary Manifestation. J Clin Med 2021;10:5796. [PMID: 34945093 DOI: 10.3390/jcm10245796] [Reference Citation Analysis]
36 Grażyńska A, Kufel J, Dudek A, Cebula M. Shear Wave and Strain Elastography in Crohn's Disease-A Systematic Review. Diagnostics (Basel) 2021;11:1609. [PMID: 34573952 DOI: 10.3390/diagnostics11091609] [Reference Citation Analysis]
37 Meredith J, Henderson P, Wilson DC, Russell RK. Combination Immunotherapy Use and Withdrawal in Pediatric Inflammatory Bowel Disease-A Review of the Evidence. Front Pediatr 2021;9:708310. [PMID: 34621712 DOI: 10.3389/fped.2021.708310] [Reference Citation Analysis]
38 Bachmann J, Le Thi G, Brückner A, Kalteis AL, Schwerd T, Koletzko S, Lurz E. Epstein-Barr Virus Prevalence at Diagnosis and Seroconversion during Follow-Up in Pediatric Inflammatory Bowel Disease. J Clin Med 2021;10:5187. [PMID: 34768707 DOI: 10.3390/jcm10215187] [Reference Citation Analysis]
39 Peters S, Cantez S, De Laffolie J; CEDATA Study Group. Implementation of exclusive enteral nutrition in pediatric patients with Crohn’s disease—results of a survey of CEDATA-GPGE reporting centers. Mol Cell Pediatr 2022;9. [DOI: 10.1186/s40348-022-00139-x] [Reference Citation Analysis]
40 Choi SY, Kang B. Adalimumab in Pediatric Inflammatory Bowel Disease. Front Pediatr 2022;10:852580. [DOI: 10.3389/fped.2022.852580] [Reference Citation Analysis]
41 Weber K, Zeißig Y, Haag C, Schmelz R, Pazmandi J, Kalinichenko A, Boztug K, Zeißig S, Aust D, Laass MW, Schuetz C. [Chronic or severe enteropathy and immunodeficiency: be prepared for a rara avis]. Z Gastroenterol 2022. [PMID: 35297030 DOI: 10.1055/a-1709-5024] [Reference Citation Analysis]
42 Cucinotta U, Romano C, Dipasquale V. Diet and Nutrition in Pediatric Inflammatory Bowel Diseases. Nutrients 2021;13:655. [PMID: 33671453 DOI: 10.3390/nu13020655] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
43 Kapoor A, Crowley E. Advances in Therapeutic Drug Monitoring in Biologic Therapies for Pediatric Inflammatory Bowel Disease. Front Pediatr 2021;9:661536. [PMID: 34123968 DOI: 10.3389/fped.2021.661536] [Reference Citation Analysis]
44 Herman R, Dumnicka P, Pieczarkowski S, Fyderek K. Induction of Remission in Pediatric Crohn's Disease Patients Assessed by the Mucosal Inflammation Noninvasive Index. J Clin Med 2021;10:5613. [PMID: 34884315 DOI: 10.3390/jcm10235613] [Reference Citation Analysis]
45 Sturm A, Atreya R, Bettenworth D, Bokemeyer B, Dignaß A, Ehehalt R, Germer C, Grunert PC, Helwig U, Herrlinger K, Kienle P, Kreis ME, Kucharzik T, Langhorst J, Maaser C, Ockenga J, Ott C, Siegmund B, Zeißig S, Stallmach A; Collaborators:. Aktualisierte S3-Leitlinie „Diagnostik und Therapie des Morbus Crohn“ der Deutschen Gesellschaft für Gastroenterologie, Verdauungs- und Stoffwechselkrankheiten (DGVS) – August 2021 – AWMF-Registernummer: 021-004. Z Gastroenterol 2022;60:332-418. [PMID: 35263784 DOI: 10.1055/a-1713-3941] [Reference Citation Analysis]
46 Labriola F, Marcato C, Zarbo C, Betti L, Catelli A, Valerii MC, Spisni E, Alvisi P. Dietary Habits of a Group of Children with Crohn’s Disease Compared to Healthy Subjects: Assessment of Risk of Nutritional Deficiencies through a Bromatological Analysis. Nutrients 2022;14:499. [DOI: 10.3390/nu14030499] [Reference Citation Analysis]
47 Herrador-López M, Martín-Masot R, Navas-López VM. EEN Yesterday and Today … CDED Today and Tomorrow. Nutrients 2020;12:E3793. [PMID: 33322060 DOI: 10.3390/nu12123793] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
48 Ha C, Kim ES, Kwon Y, Choe YH, Kim MJ, Lee SY. The Identification of a Novel Thiopurine S-Methyltransferase Allele, TPMT*45, in Korean Patient with Crohn's Disease. Pharmgenomics Pers Med 2020;13:665-71. [PMID: 33273844 DOI: 10.2147/PGPM.S279446] [Reference Citation Analysis]
49 Verburgt CM, Ghiboub M, Benninga MA, de Jonge WJ, Van Limbergen JE. Nutritional Therapy Strategies in Pediatric Crohn's Disease. Nutrients 2021;13:212. [PMID: 33450982 DOI: 10.3390/nu13010212] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
50 Din S, Gaya D, Kammermeier J, Lamb CA, Macdonald J, Moran G, Parkes G, Pollok R, Sebastian S, Segal J, Selinger C, Smith PJ, Steed H, Arnott ID. Inflammatory bowel disease clinical service recovery during the COVID-19 pandemic. Frontline Gastroenterol 2022;13:77-81. [PMID: 34966535 DOI: 10.1136/flgastro-2021-101805] [Reference Citation Analysis]
51 Steell L, Gray SR, Russell RK, MacDonald J, Seenan JP, Wong SC, Gaya DR. Pathogenesis of Musculoskeletal Deficits in Children and Adults with Inflammatory Bowel Disease. Nutrients 2021;13:2899. [PMID: 34445056 DOI: 10.3390/nu13082899] [Reference Citation Analysis]
52 Burgess CJ, Clark C, Khedim CA, Armstrong K, Henderson P, Wilson DC. Recognising and Treating Complicated Fissuring Perianal Crohn Disease: A South-East Scotland Cohort Study. J Pediatr Gastroenterol Nutr 2022;74:68-71. [PMID: 34962500 DOI: 10.1097/MPG.0000000000003285] [Reference Citation Analysis]
53 Dupont-Lucas C, Marion-Letellier R, Pala M, Guerin C, Bôle-Feysot C, Salameh E, Goichon A, Nicol L, Aziz M, Savoye-Collet C, Savoye G. Magnetic resonance colonography assessment of acute trinitrobenzene sulfonic acid colitis in pre-pubertal rats. PLoS One 2021;16:e0259135. [PMID: 34735489 DOI: 10.1371/journal.pone.0259135] [Reference Citation Analysis]
54 Verburgt CM, Heutink WP, Kuilboer LIM, Dickmann JD, van Etten-Jamaludin FS, Benninga MA, de Jonge WJ, Van Limbergen JE, Tabbers MM. Antibiotics in pediatric inflammatory bowel diseases: a systematic review. Expert Rev Gastroenterol Hepatol 2021;15:891-908. [PMID: 34148466 DOI: 10.1080/17474124.2021.1940956] [Reference Citation Analysis]
55 Wilkens R, Dolinger M, Burisch J, Maaser C. Point-of-Care Testing and Home Testing: Pragmatic Considerations for Widespread Incorporation of Stool Tests, Serum Tests, and Intestinal Ultrasound. Gastroenterology 2022:S0016-5085(21)04072-5. [PMID: 34995530 DOI: 10.1053/j.gastro.2021.10.052] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
56 Peyrin-Biroulet L, Sandborn WJ, Panaccione R, Domènech E, Pouillon L, Siegmund B, Danese S, Ghosh S. Tumour necrosis factor inhibitors in inflammatory bowel disease: the story continues. Therap Adv Gastroenterol 2021;14:17562848211059954. [PMID: 34917173 DOI: 10.1177/17562848211059954] [Reference Citation Analysis]
57 Dawson R, Wands DIF, Logan M, Bremner G, Efklides S, Benn L, Henderson P, Grant H, Meredith J, Armstrong K, Wilson DC, Gerasimidis K, Alex G, Russell RK. Comparing Effectiveness of a Generic Oral Nutritional Supplement With Specialized Formula in the Treatment of Active Pediatric Crohn's Disease. Inflamm Bowel Dis 2022:izac039. [PMID: 35259266 DOI: 10.1093/ibd/izac039] [Reference Citation Analysis]